We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.028
Bid: 0.024
Ask: 0.028
Change: 0.0005 (1.96%)
Spread: 0.004 (16.667%)
Open: 0.026
High: 0.028
Low: 0.026
Prev. Close: 0.0255
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

29 Jul 2020 12:18

RNS Number : 4985U
Supply @ME Capital PLC
29 July 2020
 

29 July 2020

Supply@Me Capital plc

("SYME") or (the "Company")

PDMR/PCA shareholding

Supply@Me has been notified by 1AF2 Srl ("1AF2"), which holds 23,91% of SYME shares, that it has transferred as loan security a number of SYME shares to three lending platforms as follows ("Lenders").

- 1,615,253,000 SYME shares transferred to High West Capital Partners LLC

- 778,571,429 SYME shares transferred to Stock Loan Solutions LLC

- 3,500,000,000 SYME shares transferred to Union Pacific Capital Ltd

The shares have been transferred to secure loans (the "Loans") to 1AF2 ("the borrower"), with a minimum two-year duration, after which period 1AF2 confirms that it intends to repay the loans. The Loans may be drawn in a series of tranches over one month and Lenders may trade pledged shares to diversify their portfolio concentration risks. Upon repayment, all 5,893,824,429 SYME shares will be returned to the borrower.

SYME has been further informed by 1AF2 that, subject to regulatory approvals, it will offer to invest funds from the capital raised into the Company's inventory funding process alongside institutions (in the Open-Funding and Self-Funding structures) as described in the Trading Update RNS of 27 July 2020.

Mr Zamboni's 18.98% shareholding in SYME held through Orchestra Group remains unchanged.

Alessandro Zamboni is a Director of 1AF2 and 1AF2 is therefore considered to be closely associated with him under the Market Abuse Regulations.

PDMR/PCA FCA Transaction Notification

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1AF2 Srl

2.

Reason for the Notification

a)

Position/status

PCA of Alessandro Zamboni, CEO of SYME

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Supply@Me Capital Plc

b)

LEI

213800ZY2C2TI2C5WQ61

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.002p each in the share capital of Supply@Me Capital plc

Identification code

ISIN: GB00BFMDJC60

b)

Nature of the Transaction

Pledge of shares for loan security at market price

c)

Price(s) and volume(s) of shares pledged

Price(s)

Volume(s)

0.075 pence

0,09 pence 0.07617 pence

 

1,615,253,000

778,571,429

3,500,000,000

 

d)

Aggregated information

Aggregated volume Price

None

e)

Date of the transactions

24 July 2020 (High West Capital Partners LLC)

28 July 2020 (Stock Loan Solutions LLC)

28 July 2020 (Union Pacific Ltd)

 

f)

Place of the transaction

London Stock Exchange, UK

 

 

Alessandro Zamboni, CEO, Supply@ME Capital plc

Paul Vann, Walbrook PR Limited: +44 (0)20 7933 8780

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFLLDDIAFII
Date   Source Headline
22nd Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20229:05 amRNSSecond Price Monitoring Extn
27th Apr 20229:00 amRNSPrice Monitoring Extension
27th Apr 20227:01 amRNSCapital Enhancement Plan & Revised Date of Results
19th Apr 20227:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.